hesperetin has been researched along with rebaudioside a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Di, G; Fan, J; Guo, C; Li, Q; Qi, X; Wang, J; Wu, X | 1 |
1 other study(ies) available for hesperetin and rebaudioside a
Article | Year |
---|---|
Improved bioavailability and anticancer efficacy of Hesperetin on breast cancer via a self-assembled rebaudioside A nanomicelles system.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diterpenes, Kaurane; Drug Carriers; Drug Compounding; Drug Liberation; Female; Hesperidin; Humans; Membrane Potential, Mitochondrial; Mice; Micelles; Nanoparticles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Solubility; Tissue Distribution; Tumor Burden | 2021 |